Since 2010, scientists have published over 23,000 peer-reviewed papers on cannabis, with the annual number of papers increasing every year.
For over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies.
“These common-sense regulatory changes are necessary and long overdue. The reality that most high-schoolers have easier access to cannabis than do our nation’s top scientists is the height of absurdity and an indictment of the current system.”
“Legislative action is necessary in this arena because the DEA has proven time and time again that it is not an honest broker in this process.”
“Over the course of our study, … we identified a significant and progressive increase in the number of patients using cannabis. In patients with chronic pain, cannabis use more than doubled during this period.”
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses.
A federal court has ordered the Drug Enforcement Administration to respond to a lawsuit charging the agency with failing to move forward with a 2016 policy to expand the total number of federally licensed marijuana cultivators.
Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research.